Sustainability & Climate

A landmark report on 2,000+ companies reveals growth is strong but selective. See why focus, vertical specialization, and core AI now beat hype.

This Valentine's, ESSENCE's WeLoveUs.shop merges love and legacy, turning gift-giving into a powerful investment in Black women-owned businesses.

The new platform integrates payments, data, and AI-driven insights from 550+ payers to combat administrative waste and give providers financial control.

With new manufacturing deals, CS Diagnostics is set to enter the competitive global hygiene market, targeting infection control from hospitals to homes.

A Bolingbrook senior care provider earns a prestigious certification, adopting an evidence-based framework that promises a new level of personalized care.

New U.S. tariffs may cause a dramatic spike in clothing prices. A new report details how the global supply chain is adapting to avert a crisis for consumers.

As new CDC data reveals autism affects 1 in 31 children, one provider is rapidly expanding its workforce and centers to address a growing public health crisis.

With its acquisition offer falling short of a majority, Cycle Pharma extends its tender for Applied Therapeutics, leaving the company's fate in the balance.

Celebrating five decades, the grocery giant launches its '50 for 50' initiative to fund food nonprofits and honors the pioneers of the natural food movement.

A new report reveals why the most innovative medicines struggle to reach patients, highlighting deep operational gaps in data, tech, and team coordination.

Crop protection giant ADAMA signals a return to adjusted net profit in 2025, crediting its 'Fight Forward' strategy for navigating a tough global market.

U.S. toy company JOYIN unveils a multi-brand strategy at Toy Fair 2026, aiming to become a key partner for retailers with its JOVA and SLOOSH lines.

Monika Alcobev's 1800 Tequila partners with Gaurav Gupta, signaling a new era of experiential marketing in India's booming luxury market.

A new report warns US drug price controls could mirror Canada's struggles, delaying access to new medicines. Is America trading innovation for affordability?

France's national railway operator SNCF partners with Finnish tech firm Teleste for a massive four-year upgrade of its passenger information displays.

A German biotech's novel oral drug for herpes is moving to Phase 2 trials, offering new hope against a widespread and often resistant virus.

Stock photo giant Dreamstime leverages AI in its largest-ever language expansion, aiming to dominate new global markets and empower creators worldwide.

With new teams in four countries, IndySoft expands its reach to meet rising demand for advanced, measurement-driven industrial asset management.

The FDA has qualified MolecuLightDX's measurement tool, a move set to standardize clinical trials, accelerate innovation, and redefine wound healing.

A new global study reveals how boards in developing economies are pioneering resilience strategies that could serve as a model for a world in constant flux.